Geisen, Christof; Kjær, Mette; Fleck, Erika; Skogen, Bjørn; Armstrong, Roisin; Behrens, Frank; Bhagwagar, Zubin; Braeuninger, Susanne; Mörtberg, Anette; Olsen, Klaus Juel; Scafer, Stephan Martin Gaston; Walter, Carmen; Seifried, Erhard; Wikman, Agneta; Kjeldsen-Kragh, Jens; Koehm, Michaela (Journal article; Tidsskriftartikkel; Peer reviewed, 2022-12-22)
Background: Fetal/neonatal alloimmune thrombocytopenia (FNAIT) is a rare and
potentially life-threatening bleeding disorder of the fetus/newborn. Antibodies against
human platelet antigen 1a (HPA-1a) are associated with the most frequent FNAIT
cases. There are no approved therapies for FNAIT prevention or treatment. RLYB211 is
a polyclonal HPA-1a hyperimmune IgG being developed to prevent ...